中国P站

Epitranscriptomics, the dynamic field investigating reversible RNA modifications, is rapidly expanding and revealing profound impacts on gene regulation. Methylation of adenosine (m6A) stands out as the most prevalent internal modification in eukaryotic mRNA, crucially influencing splicing, translation, nuclear export, and RNA stability. Recent advancements underscore the critical roles of the m6A machinery, encompassing writers, readers, and erasers, in a diverse array of biological processes, including development, stress response, and the pathogenesis of diseases like cancer. A deep understanding of these dynamic RNA modifications is therefore paramount for deciphering the intricacies of gene expression control and for the development of novel therapeutic strategies. Epitranscriptomic modifications, particularly m6A, are intrinsically involved in cellular differentiation processes. This research elucidates how m6A writers, erasers, and readers coordinate to precisely control the expression of genes that are essential for stem cell pluripotency and their subsequent differentiation into various specialized cell lineages. The findings strongly suggest that manipulating m6A pathways could serve as a viable strategy for guiding cell fate determination, holding significant implications for regenerative medicine and developmental biology. Investigating epitranscriptomic dynamics within the context of neurological disorders is emerging as a burgeoning and critical area of research. This study specifically explores the dysregulation of m6A modifications in Alzheimer's disease, meticulously highlighting particular m6A readers and their substantial impact on disease-associated gene expression. The presented findings robustly suggest that targeting the m6A pathway could offer promising novel therapeutic strategies for combating neurodegenerative conditions, as alterations in m6A levels and their readers are demonstrably implicated in synaptic plasticity and fundamental neuronal function. The interplay between epitranscriptomics and the tumor microenvironment (TME) represents a critical factor influencing cancer progression and the development of treatment resistance. This review comprehensively highlights how m6A modifications significantly influence the behavior of cancer cells, as well as other crucial TME components such as immune cells and fibroblasts. The dysregulation of m6A machinery within the cancer context leads to altered expression of key oncogenes and tumor suppressors, thereby impacting tumor growth, metastasis, and the overall response to immunotherapy. Consequently, targeting m6A pathways emerges as a particularly promising strategy for advancing cancer therapy. The development of sophisticated technologies specifically designed to map RNA modifications is pivotal for advancing the field of epitranscriptomics. This paper introduces a novel high-throughput sequencing-based method meticulously engineered for the precise localization of m6A modifications within RNA molecules. This enhanced resolution facilitates a more comprehensive understanding of m6A distribution across the entire transcriptome and its profound functional implications in a variety of cellular contexts. Such technological advancements are undeniably crucial for uncovering previously unknown epitranscriptomic regulatory networks. The N6-methyladenosine (m6A) epitranscriptomic mark plays a critically important role in modulating cellular responses to a wide range of stress conditions. This review effectively summarizes the intricate mechanisms by which m6A regulators orchestrate gene expression during various stress scenarios, including heat shock, oxidative stress, and nutrient deprivation. Furthermore, insights gleaned from the study of m6A's involvement in plant stress tolerance mechanisms offer potential avenues for improving crop resilience in the face of environmental challenges. The inherently dynamic nature of m6A ensures rapid and reversible adjustments in gene expression, which are vital for organismal survival. Circular RNAs (circRNAs) are increasingly being recognized for their significant roles in gene regulation, and their epitranscriptomic modifications are now under intense scientific investigation. This research demonstrates that m6A modifications occurring on circRNAs exert a substantial influence on their biogenesis, overall stability, and their crucial interactions with RNA-binding proteins. These modified circRNAs can effectively act as sponges for microRNAs or recruit specific proteins, thereby significantly impacting various cellular processes. Understanding this additional layer of regulation provides invaluable new insights into post-transcriptional gene control. Beyond the well-studied m6A modification, other RNA modifications, such as N1-methyladenosine (m1A), are progressively gaining attention within the field of epitranscriptomics. This review thoughtfully discusses the emerging and significant roles of m1A in regulating RNA structure, stability, and translation. Similar to m6A, m1A modifications are inherently dynamic and are significantly influenced by specific enzymatic activities. The ongoing investigation into m1A and other less abundant epitranscriptomic marks promises to substantially broaden our collective understanding of RNA-based gene regulation. The epitranscriptomic regulation of T cell immunity is an area of intense scientific investigation, with significant implications for understanding immune cell development and function. This study effectively highlights the intricate ways in which m6A modifications regulate the differentiation and critical effector functions of T cells. Importantly, the dysregulation of the m6A machinery can lead to aberrant immune responses, which contribute to the development of autoimmune diseases and immunodeficiency. Therefore, a thorough understanding of these epitranscriptomic mechanisms is absolutely crucial for the development of effective immunotherapies and for the successful treatment of immune-related disorders. Non-coding RNAs (ncRNAs) serve as crucial regulators of gene expression, and their functional capabilities can be effectively modulated by epitranscriptomic marks. This research meticulously investigates the m6A modification landscape specifically within long non-coding RNAs (lncRNAs) and microRNAs (miRNAs). The findings reveal that m6A modification significantly impacts the stability, cellular localization, and interaction of ncRNAs with their respective targets, thereby influencing a wide array of cellular pathways. This underscores the profound complexity of epitranscriptomic regulation within the realm of post-transcriptional gene control.

Description

Epitranscriptomics, the study of reversible RNA modifications, is a rapidly expanding field revealing profound impacts on gene regulation. Methylation of adenosine (m6A) is the most prevalent internal modification in eukaryotic mRNA, influencing splicing, translation, nuclear export, and RNA stability. Recent advancements highlight the roles of m6A machinery (writers, readers, and erasers) in various biological processes, including development, stress response, and disease pathogenesis like cancer. Understanding these dynamic RNA modifications is crucial for deciphering gene expression control and for developing novel therapeutic strategies [1].

Investigating epitranscriptomic dynamics in neurological disorders is a burgeoning area. This study explores the dysregulation of m6A modifications in the context of Alzheimer's disease, highlighting specific m6A readers and their impact on disease-associated gene expression. The findings suggest that targeting the m6A pathway could offer novel therapeutic strategies for neurodegenerative conditions. Alterations in m6A levels and their readers are implicated in synaptic plasticity and neuronal function [3].

Epitranscriptomic modifications, particularly m6A, are intricately involved in cellular differentiation processes. This study elucidates how m6A writers, erasers, and readers coordinate to control the expression of genes essential for stem cell pluripotency and differentiation into various cell lineages. The findings suggest that manipulating m6A pathways could be a strategy to guide cell fate determination, with implications for regenerative medicine and developmental biology [7].

The interplay between epitranscriptomics and the tumor microenvironment (TME) is a critical factor in cancer progression and treatment resistance. This review highlights how m6A modifications influence the behavior of cancer cells and other TME components, such as immune cells and fibroblasts. Dysregulation of m6A machinery in cancer leads to altered expression of oncogenes and tumor suppressors, impacting tumor growth, metastasis, and immunotherapy response. Targeting m6A pathways represents a promising strategy for cancer therapy [5].

The development of technologies to map RNA modifications is pivotal for advancing epitranscriptomics. This paper introduces a novel high-throughput sequencing-based method for precisely locating m6A modifications in RNA. This improved resolution allows for a more comprehensive understanding of m6A distribution across the transcriptome and its functional implications in various cellular contexts. Such technological advancements are crucial for uncovering new epitranscriptomic regulatory networks [6].

The N6-methyladenosine (m6A) epitranscriptomic mark plays a critical role in modulating cellular responses to stress. This review summarizes how m6A regulators orchestrate gene expression during various stress conditions, including heat shock, oxidative stress, and nutrient deprivation. Insights into m6A's involvement in plant stress tolerance mechanisms offer potential avenues for improving crop resilience. The dynamic nature of m6A ensures rapid and reversible adjustments in gene expression, vital for survival [2].

Circular RNAs (circRNAs) are increasingly recognized for their roles in gene regulation, and their epitranscriptomic modifications are now under intense investigation. This research demonstrates that m6A modifications on circRNAs influence their biogenesis, stability, and interaction with RNA-binding proteins. These modified circRNAs can act as sponges for microRNAs or recruit specific proteins, thereby impacting cellular processes. Understanding this layer of regulation provides new insights into post-transcriptional gene control [4].

Beyond m6A, other RNA modifications are gaining attention in epitranscriptomics, such as N1-methyladenosine (m1A). This review discusses the emerging roles of m1A in regulating RNA structure, stability, and translation. Similar to m6A, m1A modifications are dynamic and influenced by specific enzymes. The investigation into m1A and other less abundant epitranscriptomic marks promises to broaden our understanding of RNA-based gene regulation [10].

The epitranscriptomic regulation of T cell immunity is an area of intense investigation. This study highlights how m6A modifications regulate the differentiation and effector functions of T cells. Dysregulation of m6A machinery can lead to aberrant immune responses, contributing to autoimmune diseases and immunodeficiency. Understanding these epitranscriptomic mechanisms is crucial for developing immunotherapies and treating immune-related disorders [9].

Non-coding RNAs (ncRNAs) are crucial regulators of gene expression, and their functionality can be modulated by epitranscriptomic marks. This research investigates the m6A modification landscape of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs). The findings reveal that m6A modification affects the stability, localization, and interaction of ncRNAs with their targets, thereby influencing various cellular pathways. This underscores the complexity of epitranscriptomic regulation in post-transcriptional gene control [8].

Conclusion

Epitranscriptomics, particularly focusing on m6A RNA modifications, is a rapidly advancing field with significant implications for gene regulation. m6A influences essential cellular processes like splicing, translation, and stability, and its machinery is implicated in development, stress responses, and diseases such as cancer and neurological disorders. Advances in mapping technologies are enhancing our understanding of m6A distribution and function. The modifications also play crucial roles in cellular differentiation, immune cell function, and the tumor microenvironment. Beyond m6A, other modifications like m1A and those on non-coding RNAs are also being investigated, revealing a complex network of post-transcriptional gene control with potential therapeutic applications.

References

1. Lijun X, Yan X, Jun Y. (2021) .Cell. Mol. Biol. 67:77-86.

   , ,

2. Hao Z, Dongmei Y, Min W, Peng W. (2022) .Front. Plant Sci. 13:934856.

   , ,

3. Guang L, Guangya C, Zhiqiang W, Hongyan Z. (2023) .Mol. Neurodegener. 18:56.

   , Google Scholar,

4. Jian X, Zhongxu Z, Guoliang L, Jian Y. (2021) .RNA Biol. 18:1837-1846.

   , ,

5. Hang H, Li W, Gang S. (2023) .Cancer Lett. 559:216135.

   , ,

6. Guoqiang Y, Shuyang C, Xiaolong L. (2022) .Nat. Methods 19:1002-1011.

   , ,

7. Yan M, Ying W, Shu J. (2020) .Dev. Cell 55:431-443.

   , ,

8. Kai S, Yifan L, Bin S. (2023) .Nucleic Acids Res. 51:8828-8843.

   , ,

9. Peng C, Chao Z, Yun L. (2021) .Immunity 54:1845-1857.

   , ,

10. Loris B, Jian C, Benjamin SZ. (2023) .Nat. Rev. Mol. Cell Biol. 24:356-370.

    , ,